Why Is INTUITIVE SURGICAL I (ISRG) Stock Down Today?

Intuitive Surgical shares fell 14.15% to $345.42 in a session marked by investor concern over muted guidance and analyst price target cuts. The stock led decliners in the S&P 500 after reporting second-quarter revenue growth and issuing forward-looking projections that fell short of expectations. Analysts reduced price targets, and insiders sold shares, amplifying the sell-off.

What Happened

The stock's sharp decline came following a revenue increase of 19% in the second quarter, which failed to offset concerns over the company's future growth trajectory. Guidance for da Vinci procedure growth was described as muted, leading to a wave of price target reductions from analysts. Jefferies analysts noted the results and guidance fell below expectations, while Piper Sandler and Raymond James lowered their price targets to $470 and $483 respectively. The stock sank to a 52-week low, with investors reacting to the combination of weak guidance and analyst skepticism. The CEO and other executives did not provide additional commentary to reassure the market.

What The Data Shows

The stock has declined 15.3% over the last eight sessions, from $418.83 to $354.69. Insiders have sold six times in the last 90 days, totaling $2.8 million. Recent transactions include sales by EVP Mark Brosius and EVP Gary Loeb. Congressional trades show Rep. Ro Khanna has both bought and sold ISRG in the last 90 days. The stock's fundamentals include a P/E of 39.6, a 20.7% year-to-date revenue increase, and a 28.4% net margin. However, the recent sell-off has pushed the stock near its 52-week low of $344.55.

What To Watch

Investors should monitor the company's next earnings report for further clarity on its growth outlook. Coverage of the stock remains active, with eight stories published in the last 36 hours, and analysts are likely to continue adjusting their views based on new data.